Clinical Pharmacist Intervention
Sponsors
University of Massachusetts, Worcester, Hacettepe University, University of Jordan, Monash University Malaysia, Sykehuset Innlandet HF
Conditions
Adverse Drug EventAtrial FibrillationBleedingCancerCancer PainCardiovascular DiseasesClinical PharmacyDrug-Drug Interaction
Unknown Phase
LEAVE Safe With DOACs
CompletedNCT04068727
Start: 2019-12-02End: 2022-09-14Updated: 2024-02-20
Drug-Related Problems in Neonatal Patients
NCT04899960
Start: 2020-02-01End: 2021-11-01Target: 512Updated: 2021-09-02
The Impact of Clinical Pharmacist in the Identification and Management of Treatment Related Problems in the Surgery Ward
CompletedNCT04941820
Start: 2019-09-29End: 2020-02-06Updated: 2021-06-28
Clinical Pharmacists' Intervention on Pain Management in Cancer Patients
CompletedNCT05021393
Start: 2022-05-01End: 2023-06-01Updated: 2024-03-26
A Study to Investigate Health Related Quality of Life With a Pharmacist Intervention Compared to Treatment as Usual in Participants With Severe Mental Illness and Substance Use Disorder Receiving Treatment From FACT Teams.
Not yet recruitingNCT07597863
Start: 2026-05-01End: 2031-02-01Target: 160Updated: 2026-05-19